These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26189131)

  • 1. Raloxifene trial in postmenopausal woman with treatment-resistant schizophrenia.
    Tharoor H; Goyal A
    Arch Womens Ment Health; 2015 Oct; 18(5):741-2. PubMed ID: 26189131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial.
    Usall J; Huerta-Ramos E; Labad J; Cobo J; Núñez C; Creus M; Parés GG; Cuadras D; Franco J; Miquel E; Reyes JC; Roca M;
    Schizophr Bull; 2016 Mar; 42(2):309-17. PubMed ID: 26591005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia.
    Kulkarni J; Gurvich C; Lee SJ; Gilbert H; Gavrilidis E; de Castella A; Berk M; Dodd S; Fitzgerald PB; Davis SR
    Psychoneuroendocrinology; 2010 Sep; 35(8):1142-7. PubMed ID: 20171784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial.
    Usall J; Huerta-Ramos E; Iniesta R; Cobo J; Araya S; Roca M; Serrano-Blanco A; Teba F; Ochoa S
    J Clin Psychiatry; 2011 Nov; 72(11):1552-7. PubMed ID: 21903021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of raloxifene on symptoms and cognitive functioning in a postmenopausal schizophrenia patient: a case report.
    Huerta-Ramos E; Ochoa S; Roca M; Miquel E; Usall J
    Arch Womens Ment Health; 2015 Apr; 18(2):259-261. PubMed ID: 25586253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial.
    Huerta-Ramos E; Iniesta R; Ochoa S; Cobo J; Miquel E; Roca M; Serrano-Blanco A; Teba F; Usall J
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):223-31. PubMed ID: 24342775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial.
    Huerta-Ramos E; Labad J; Cobo J; Núñez C; Creus M; García-Parés G; Cuadras D; Franco J; Miquel E; Reyes JC; Marcó-García S; ; Usall J
    Eur Arch Psychiatry Clin Neurosci; 2020 Sep; 270(6):729-737. PubMed ID: 31728631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity proteins 1 and 4 in peripheral blood mononuclear cells in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial.
    Vila È; Huerta-Ramos E; Núñez C; Usall J; Ramos B
    Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):941-948. PubMed ID: 30167782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial.
    Weiser M; Levi L; Burshtein S; Hagin M; Matei VP; Podea D; Micluția I; Tiugan A; Păcală B; Grecu IG; Noy A; Zamora D; Davis JM
    J Clin Psychiatry; 2017 Jul; 78(7):e758-e765. PubMed ID: 28541645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial.
    Kianimehr G; Fatehi F; Hashempoor S; Khodaei-Ardakani MR; Rezaei F; Nazari A; Kashani L; Akhondzadeh S
    Daru; 2014 Jul; 22(1):55. PubMed ID: 25012765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of add-on raloxifene in schizophrenia.
    Raveendranathan D; Shivakumar V; Jayaram N; Rao NP; Venkatasubramanian G
    Arch Womens Ment Health; 2012 Apr; 15(2):147-148. PubMed ID: 22290018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia.
    Khan MM
    CNS Drugs; 2016 Jul; 30(7):589-601. PubMed ID: 27193386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mood effect of raloxifene in postmenopausal women.
    Jarkova NB; Martenyi F; Masanauskaite D; Walls EL; Smetnik VP; Pavo I
    Maturitas; 2002 May; 42(1):71-5. PubMed ID: 12020982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive raloxifene for postmenopausal women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zhu XM; Zheng W; Li XH; Cai DB; Yang XH; Ungvari GS; Ng CH; Wang XP; Kulkarni J; Grigg J; Ning YP; Xiang YT
    Schizophr Res; 2018 Jul; 197():288-293. PubMed ID: 29395611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia.
    Khodaie-Ardakani MR; Khosravi M; Zarinfard R; Nejati S; Mohsenian A; Tabrizi M; Akhondzadeh S
    Acta Med Iran; 2015; 53(6):337-45. PubMed ID: 26069170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of raloxifene on left ventricular hypertrophy in postmenopausal women: A prospective, randomized, and controlled study.
    Bal UA; Atar İ; Öktem M; Zeyneloğlu HB; Yıldırır A; Kuşcu E; Müderrisoğlu H
    Anatol J Cardiol; 2015 Jun; 15(6):480-4. PubMed ID: 25430415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of substantial effects of raloxifene on thyroxine-binding globulin in postmenopausal women: dependency on thyroid status.
    Duntas LH; Mantzou E; Koutras DA
    Thyroid; 2001 Aug; 11(8):779-82. PubMed ID: 11525272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raloxifene as a treatment for cognition in women with schizophrenia: the influence of menopause status.
    Gurvich C; Hudaib A; Gavrilidis E; Worsley R; Thomas N; Kulkarni J
    Psychoneuroendocrinology; 2019 Feb; 100():113-119. PubMed ID: 30299258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone modulation: a novel therapeutic approach for women with severe mental illness.
    Kulkarni J; Gurvich C; Gilbert H; Mehmedbegovic F; Mu L; Marston N; Gavrilidis E; de Castella A
    Aust N Z J Psychiatry; 2008 Jan; 42(1):83-8. PubMed ID: 18058448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raloxifene reduces impedance to flow within the uterine artery in early postmenopausal women: a 2-year randomized, placebo-controlled, comparative study.
    Post MS; van der Mooren MJ; van Baal WM; Neele SJ; Netelenbos JC; Kenemans P
    Am J Obstet Gynecol; 2001 Sep; 185(3):557-62. PubMed ID: 11568777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.